Ultraviolet radiation thwarts graft-versus-host disease in mice after hematopoietic stem cell transplantation. The treatment kills host Langerhans cells in the skin, which contribute to this deadly disease (pages 510–517).
This is a preview of subscription content, access via your institution
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Shlomchik, W.D. et al. Science 285, 412–415 (1999).
Ruggeri, L. et al. Science 295, 2097–2100 (2002).
Merad, M. et al. Nat. Med. 10, 510–517 (2004).
Zhang, Y. et al. J. Immunol. 169, 7111–7118 (2002).
Teshima, T. et al. Nat. Med. 8, 575–581 (2002).
Ratzinger, G., Reagan, J.L., Heller, G., Busam, K.J. & Young, J.W. Blood 101, 1422–1429 (2003).
D'Sa, S. et al. Br. J. Haematol. 123, 309–322 (2002).
Marks, D.I. et al. Blood 100, 3108–3114 (2002).
Merad, M. et al. Nat. Immunol. 3, 1135–1141 (2002).
Rights and permissions
About this article
Cite this article
Emerson, S. Tanning before transplant: lancing the Langerhans cell. Nat Med 10, 451–452 (2004). https://doi.org/10.1038/nm0504-451